A detailed history of Envestnet Asset Management Inc transactions in Insmed Inc stock. As of the latest transaction made, Envestnet Asset Management Inc holds 241,131 shares of INSM stock, worth $17.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
241,131
Previous 175,464 37.42%
Holding current value
$17.8 Million
Previous $11.8 Million 49.73%
% of portfolio
0.01%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$62.0 - $79.01 $4.07 Million - $5.19 Million
65,667 Added 37.42%
241,131 $17.6 Million
Q2 2024

Aug 08, 2024

BUY
$22.0 - $69.71 $2.62 Million - $8.31 Million
119,214 Added 211.94%
175,464 $11.8 Million
Q1 2024

May 13, 2024

SELL
$25.72 - $29.94 $145,446 - $169,310
-5,655 Reduced 9.13%
56,250 $1.53 Million
Q4 2023

Feb 13, 2024

BUY
$23.42 - $31.74 $45,036 - $61,036
1,923 Added 3.21%
61,905 $1.92 Million
Q3 2023

Nov 13, 2023

BUY
$19.86 - $26.93 $265,905 - $360,565
13,389 Added 28.74%
59,982 $1.51 Million
Q2 2023

Aug 04, 2023

BUY
$16.44 - $21.1 $2,087 - $2,679
127 Added 0.27%
46,593 $983,000
Q1 2023

May 11, 2023

BUY
$16.26 - $21.73 $155,722 - $208,108
9,577 Added 25.96%
46,466 $792,000
Q4 2022

Feb 07, 2023

SELL
$16.98 - $23.15 $61,892 - $84,381
-3,645 Reduced 8.99%
36,889 $737,000
Q3 2022

Nov 10, 2022

BUY
$20.88 - $28.21 $60,739 - $82,062
2,909 Added 7.73%
40,534 $873,000
Q2 2022

Aug 03, 2022

BUY
$17.07 - $25.71 $82,772 - $124,667
4,849 Added 14.79%
37,625 $742,000
Q1 2022

May 04, 2022

BUY
$20.42 - $28.13 $68,121 - $93,841
3,336 Added 11.33%
32,776 $770,000
Q4 2021

Feb 04, 2022

BUY
$25.89 - $33.45 $148,505 - $191,869
5,736 Added 24.2%
29,440 $802,000
Q3 2021

Oct 07, 2021

BUY
$22.46 - $29.47 $39,507 - $51,837
1,759 Added 8.02%
23,704 $653,000
Q2 2021

Aug 04, 2021

SELL
$24.17 - $36.01 $45,463 - $67,734
-1,881 Reduced 7.89%
21,945 $625,000
Q1 2021

May 04, 2021

BUY
$32.28 - $44.3 $71,467 - $98,080
2,214 Added 10.24%
23,826 $812,000
Q4 2020

Feb 02, 2021

BUY
$31.45 - $40.54 $32,456 - $41,837
1,032 Added 5.01%
21,612 $719,000
Q3 2020

Oct 09, 2020

BUY
$26.0 - $34.5 $139,958 - $185,713
5,383 Added 35.42%
20,580 $661,000
Q2 2020

Jul 08, 2020

BUY
$14.11 - $29.42 $11,908 - $24,830
844 Added 5.88%
15,197 $419,000
Q1 2020

Apr 23, 2020

BUY
$13.63 - $33.98 $195,631 - $487,714
14,353 New
14,353 $230,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.